London, UK; Brentwood, TN, US: 10 April 2007 - Protherics PLC (“Protherics” or the “Company”), the international biopharmaceutical company focused on critical care and cancer, announces that, today, the following 6 monthly block listing return in respect of the Company’s Savings Related Share Option Scheme has been lodged with the FSA in accordance with Listing Rule 3.5.6.
